This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
A beginner-friendly sequence to implement Zero Based Budgeting, with actionable steps and easy milestones.
20,167 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
U.S. policymakers confront a volatile oil backdrop and rising pump prices, weighing reserves, production, and demand ...
Many retirees are surprised to learn that part of their social security benefit can be taxed. This guide explains how...
A quiet billionaire behind a creator economy machine has passed away. This piece explains what that means for million...
A former employee has filed a class-action complaint against US Mortgage Corp. over a May 2025 data breach that expos...
A 130-day tenure ends as the white house crypto czar departs, leaving a policy footprint that favors banks and infras...
Kyndryl’s latest quarterly results triggered a notable stock move as earnings fell short of expectations. This articl...
A California court has approved a $250 million class-action settlement alleging false advertising around Siri feature...
Choosing between IXUS and VYMI can shape your international exposure. This guide breaks down what each fund holds, co...
When markets punish uncertainty, contrarian investors can find hidden upside. This article highlights three strugglin...
Two researchers are launching a dedicated effort to bring sustainability back into the AI conversation, promising mea...
As May 2026 unfolds, smart investors are looking for durable growth in healthcare. Here are three standout names, why...